Spleen CT1 Fibroblastic Reticular Cell (Gene Set)

Dcc Asset:

HuBMAP ASCT-B.gmt

Processed File (Entity type)

Dcc:

HuBMAP

DCC (Entity type)

Description:BST1

Analyze

Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with Spleen_CT1_Fibroblastic Reticular Cell.

GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with Spleen_CT1_Fibroblastic Reticular Cell.

CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with Spleen_CT1_Fibroblastic Reticular Cell.

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Spleen_CT1_Fibroblastic Reticular Cell.

Results found

Linked to

	Label	Description
	MADCAM1 Gene (Entity type)	mucosal vascular addressin cell adhesion molecule 1
	NGFR Gene (Entity type)	nerve growth factor receptor
	IL7 Gene (Entity type)	interleukin 7

MADCAM1

Gene (Entity type)

mucosal vascular addressin cell adhesion molecule 1

NGFR

Gene (Entity type)

nerve growth factor receptor

IL7

Gene (Entity type)

interleukin 7

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.